HomeLocal NewsNigeria records 220 more Monkeypox cases from 29 states, 4 deaths - FG

Nigeria records 220 more Monkeypox cases from 29 states, 4 deaths – FG

Date:

Related stories

Kano retirees receive long-awaited benefits

Kano State Governor, Abba Kabir Yusuf, has reaffirmed his...

Women banned from Kano mobile phone market after 7pm

The leadership of the Farm Centre mobile phone market...

15-year-old presides over Kano assembly

The Speaker of the Kano State House of Assembly,...

Mass Education: FG flags-off N4bn critical infrastructure projects

The Federal Government has flagged-off construction of N4 billion...

KEDCO confirms power supply boost after repairs

The Kano Electricity Distribution Company (KEDCO) has announced significant...
spot_img

The Nigeria Centre for Disease Control (NCDC) has confirmed that there are 220 cases of Monkeypox from 530 suspected victims, with four deaths recorded from 29 states in Nigeria as of August 14, 2022.

This was made known on Tuesday by the Director General of Nigeria Centre for Disease Control (NCDC), Dr. Ifedayo made at the Ministerial Press briefing on COVID-19 Response and Development in the Health Sector in Abuja.

He explained that the Center is looking into obtaining treatments as a key priority to offer people who are at the highest risk of severe disease, hospitalization and deaths as monkeypox vaccine may not be available until 2023.

Dr. Adetifa said a lot more doses will become available but because of challenges with manufacturing factories and unexpected uptick in monkeypox cases.

“There are 220 confirmed cases from 530 suspected cases of Monkeypox and four deaths from 29 states in the country as of August 14, 2022.

“Since the first of January 2022, 96 countries in the world have reported more than a total of 40,000 confirmed monkeypox cases including 12 deaths.

“We are also looking into obtaining treatments as a key priority so that we have an option to offer people who are at the highest risk of severe disease, hospitalization and deaths.

“As we know the situation with monkeypox vaccine access is very topical, but there are not enough doses of vaccines. But given our own local epidemiology, we believe that looking for therapeutic options is the way to go” he stated.

 

Subscribe

Latest stories

LEAVE A REPLY

Please enter your comment!
Please enter your name here